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Structure–function relationshipSchlafen 3 (Slfn3)mediates rodent enterocyte differentiation in vitro and in vivo, required for intestinal function.
Little is known about Schlafen protein structure–function relationships. To deﬁne the Slfn3 domain that pro-
motes differentiation, we studied villin and sucrase isomaltase (SI) promoter activity in Slfn3-null human
Caco-2BBE cells transfected with full-length rat Slfn3 DNA or truncated constructs. Confocal microscopy and
Western blots showed that Slfn3 is predominantly cytosolic. Villin promoter activity, increased by wild type
Slfn3, was further enhanced by adding a nuclear exclusion sequence, suggesting that Slfn3 does not affect tran-
scription by direct nuclear action. We therefore sought to dissect the region in Slfn3 stimulating promoter activ-
ity. Since examination of the Slfn3 N-terminal region revealed sequences similar to both an aminopeptidase
(App) and a divergent P-loop resembling those in NTPases, we initially divided Slfn3 into an N-terminal domain
containing the App and P-loop regions, and a C-terminal region. Only the N-terminal construct stimulated
promoter activity. Further truncation indicated that both the App and the smaller P-loop constructs enhanced
promoter activity similarly to the N-terminal sequence. Point mutations within the N-terminal region (R128L,
altering a critical active site residue in the App domain, and L212D, conserved in Schlafens but variable in
P-loop proteins) did not affect activity. These results show that Slfn3 acts in the cytosol to trigger a secondary
signal cascade that elicits differentiation marker expression and narrows the active domain to the third of the
Slfn3 sequence homologous to P-loop NTPases, a ﬁrst step in understanding its mechanism of action.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Schlafen (Slfn) proteins were ﬁrst described in the mouse where
they were shown to be differentially expressed during thymocyte mat-
uration and T-cell activation [1]. Although most studies have examined
the role of Slfn proteins in the immune response [2–8], some Slfns may
inﬂuence development, cell differentiation or the control of tumorigen-
esis [9–14]. Our laboratory has focused on Slfn3 and rat intestinal
epithelial cell differentiation, which is important in healthy intestinal
function for absorption and barrier function, as well as in disease
processes such as short gut syndrome, infectious enteritis, and inﬂam-
matory bowel disease [15–17]. We have previously demonstrated that
Slfn3 promotes differentiation in rat intestinal epithelial cells (IEC)
in vitro and in vivo [18–20]. In vitro, Slfn3 expression in IEC-6 cells is7 Wilson Road, 4179 BPS, East
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speciﬁc siRNA lowers basal and blocks stimulated activity of dipeptidyl
dipeptidase 4 (Dpp4), a canonical marker of enterocytic differentiation
[18]. In vivo, mid-intestinal Slfn3 expression increases with gestational
age; it decreases in the adult rat jejunal epithelium when it becomes
atrophic because of loss of interaction with luminal contents [9,20].
Furthermore, instillation of a Slfn3 adenovirus in the intestinal lumen
enhances epithelial mRNA and protein levels of enterocytic differentia-
tion markers. Reducing endogenous Slfn3 with small interfering RNA
conversely reduces epithelial expression of these markers [20].
Slfn family members, widely expressed in mammals, are classiﬁed
into three groups according to sequence homology and molecular size
as short (Slfn 1, 2), intermediate (Slfn 3, 4, 12) or long (Slfn 5, 8–11, 14)
[1,21]. These broad classiﬁcations are indicative of how little is known
about the molecular functions of Schlafens. Intermediate and long Slfns
share a highly conserved “SWADL” (Ser-Trp-Ala-Asp-Leu) domain of
unknown function, while long Slfns are characterized by a C-terminal
extension that contains sequence motifs homologous to members of
the superfamily I of DNA/RNA helicases [4,22,23]. All Slfns contain a
“Slfn box” adjacent to a divergent AAA domain, and previous researchers
have suggested that SlfnsmayhaveATP/GTP binding functions similar to
the classical AAA superfamily of proteins [4,24]. Identiﬁcation of these
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protein degradation and folding, vesicle transport and transcription
(AAA domain) or DNA/RNA metabolism (helicase domain) [25].
Despite identiﬁcation of broad commonalities, the mechanisms by
which Slfns act remain largely unknown. Subcellular localization often
provides clues to protein function. The short and intermediate Slfns 1,
2 and 4 localize chieﬂy in the cytosol, while the longer Slfns 5, 9 and
11, some of which contain a nuclear localization sequence, are predom-
inantly nuclear [23]. Although these observations suggest that individu-
al Slfns may have speciﬁc roles, they do not explain most published
results. We and others have shown that some of the predominantly
cytoplasmic intermediate and short Slfns (Slfns 3, 4 and 12, and Slfns
1 and 2, respectively) promote differentiation and/or inhibit cell prolifer-
ation, often by affecting promoter activity or the abundance of cell cycle
proteins [11,12,22]. Conversely, although some long Slfns co-localize
with an active form of RNA polymerase II, to date, none of the long
Slfns have been reported to have direct nuclear action. Indeed, Slfn11
inhibits HIV protein synthesis by binding to tRNA [26], a cytoplasmic
action.
The current study focuses in on the molecular function of Slfn3 by
deﬁning its closest homologs and testing the activity of the correspond-
ing Slfn3 domains. Mouse Slfn4 had been shown to be located in the
cytosol but the distribution of the highly homologous mSlfn3 had not
been tested [23]. Therefore, we ﬁrst conﬁrmed that endogenous rSlfn3
is predominantly cytosolic in rat IEC-6 intestinal epithelial cells. Then
we transfected human Caco-2 cells that do not express Slfn3 with a
rat EGFP-Slfn3 plasmid to demonstrate that while the Slfn3 protein
remained predominantly cytosolic in these cells, it nevertheless
enhanced villin promoter activity, which reﬂects downstream activity
associated with colon differentiation. Because a small amount of Slfn3
immunoreactivity appeared within the nucleus, we added a nuclear ex-
clusion sequence to the Slfn3 protein to target it to the cytoplasm. Slfn3
still stimulated villin promoter activity when it was excluded from the
nucleus via the nuclear exclusion sequence. Since the 3-dimensional
and coarser domain structure of Slfn3 is unknown,we utilized structural
homology modeling techniques to predict functional regions in the
rSlfn3 protein from its sequence, and then tested these functions by
site-directed and truncation mutagenesis followed by villin reporter
assay. Our results support that Slfn3 acts in the cytosol to initiate a
signaling cascade that affects nuclear promoter activity and differen-
tiation marker expression. Furthermore, our analysis narrowed the
segment of rSlfn3 responsible for stimulating promoter activity to a
175 residue region in the N-terminal half, matching the most compact
known folded structure of a P-loop domain. Demonstrating cytoplasmic
activity and P-loop homology for Slfn3 provides the ﬁrst steps in deﬁn-
ing its mechanism of action.
2. Methods
2.1. Cell culture
The rat non-transformed intestinal epithelial IEC-6 and the human
Caco-2BBE cell lineswere obtained fromATCC (Manassas, VA) andmain-
tained in Dulbecco's Modiﬁed Essential Eagle's Medium supplemented
with 10% FBS as described by us previously [18–20]. We used Caco-2
cells transfected with the full-length pEGFP-C1/Slfn3 plasmid or
truncated/mutated constructs for the confocal cellular localization and
luciferase activity studies described below.
2.2. Western blot
IEC-6 cells were lysed at conﬂuence and cytosolic and nuclear frac-
tions prepared using a kit from BioVison, Inc. (Milpitas, CA) according
to themanufacturer's directions. Protein concentrationwas determined
via BCA (Thermo Fisher, Rockford, IL). The proteinswere then separated
by SDS-Page electrophoresis, transferred to nitrocellulose membranesand exposed to antibodies to Slfn3 (Santa Cruz Biotechnology, Santa
Cruz, CA) and cytosolic (Rho-GDI; EMD Millipore, Billerica, MA) and
nuclear (lamin B1; Abcam, Cambridge, MA) markers. Detection was
accomplished on an Odyssey Infrared Imaging System using Li-Cor
Biosciences antibodies (Lincoln, NB). Densitometry was performed on
a Kodak 440CF Image Station (Rochester, NY).
2.3. Rat Slfn3 (rSlfn3) truncation/point mutation design
2.3.1. Region of aminopeptidase homology
The N-terminal region (residues 1–324) in rSlfn3 was found to
match two protein structural folds with different functions. First
identiﬁed was a putative leucyl M17 cytosolic aminopeptidase from
Staphylococcus aureus, in Protein Data Bank (PDB) entry 3kzw chain
A; this structurewas determined byDr. BoguslawNocek of theMidwest
Center for Structural Genomics. The rSlfn3-aminopeptidase similarity
was detected by performing protein BLAST [27] against all sequences
in the PDB [28]. The alignment of residues 69–302 in rSlfn3 to the
aminopeptidase (Supplementary Fig. A) corresponds to its complete
catalytic domain except for a short C-terminal beta-strand. The struc-
ture of the leucyl aminopeptidase domain matched by rSlfn3 is shown
in Supplementary Fig. B, with its catalytic site indicated by the three
carboxylate side chains at center. By homology with other aminopepti-
dases, this cleft positions the peptidyl substrate with its amino terminal
peptide bond adjacent to the carboxylates.
2.3.2. Mutant design to test aminopeptidase homology
To test whether rSlfn3 activity localizes to the N-terminal
aminopeptidase-like (App) domain, a construct was designed to
truncate the rSlfn3 sequence 15 residues after the App domain match
(Supplementary Fig. A), as shown in Fig. 3A. This truncation position
allowed for the inclusion of the sequence corresponding to the beta-
strand at the terminus of the catalytic domain in 3kzw, followed by
several residues, to allow for typical C-terminal structural ﬂexibility
without affecting the integrity of the App domain. Secondly, a site-
directed mutation was made to the conserved Arg128 in rSlfn3, which
conserves charge and potential metal-binding activity with the critical
aminopeptidase active-site metal ligand, Lys259. The Arg128Leu muta-
tion is conservative in side chain shape and bulk,while losing the ability
to bind metal. This mutation tests conservation of the catalytic site
between Leu aminopeptidases and rSlfn3.
2.3.3. AAA P-loop domain homology
When searching the larger non-redundant protein sequence data-
base, BLAST identiﬁed a Conserved Domain match for rSlfn3 [29],
corresponding to the AAA_4 or divergent AAA domain superfamily
(Pfam04326). The expectation value for this sequence match, shown
in Supplementary Fig. C, was 2.75 × 10−08, indicating a very low prob-
ability of occurring at random. The AAA domain match extends from
residue 199 to 302 in rSlfn3 (sequence EVK… ERFC), beginning halfway
into the putative App domain match with rSlfn3, and ending 19 resi-
dues after the App domain (Fig. 3A). Another tool, InterProScan [30],
also identiﬁed residues 203–305 in rSlfn3 as matching the AAA+ su-
perfamily of ring-shaped P-loop NTPases, with a similar expectation
value of 4.7 × e−08. The shortest stably folded example of a P-loop
domain in the Protein Data Bank is entry 3N70. This 3-dimensional
structure provides a context for assessing the P-loop region of homology
with rSlfn3 and designing mutants (Fig. 3B).
2.3.4. Mutations testing activity of the P-loop region of rSﬂn3
A P-loop domain mutant was designed for rSlfn3 based on N-
terminal and C-terminal truncation, as shown in Fig. 3A, incorporating
the region of highest conservation with divergent AAA P-loops. This
construct focused on the correspondence with the P-loop crystal
structure (PDB entry 3n70), since it folds stably without additional
sequence. For the P-loop domain construct, several residues in rSlfn3
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avoid domain destabilization from ﬂexible termini. This construct
removes 81 residues from the N-terminal region of rSlfn3 predicted as
homologous to the aminopeptidase (starting at residue 69: DFS …
FLKSR), and thus also effectively tests whether the P-loop rather than
the aminopeptidase domain conserves villin promoter activity.
Finally, a site-directed mutation was made in the Leu212 position,
which is highly conserved in Schlafens and immediately precedes the
motif most highly conserved between Schlafens and P-loop domains
(PQTVSS…). The Leu212Asp mutation is isosteric but greatly changes
the chemical character of this residue. P-loop domains tolerate hydro-
phobic, polar and charged substitution in this position, so Leu212Asp
would be expected to maintain activity if rSlfn3 acts as a P-loop, and
to lose function if rSlfn3 conservation of Leu212 were required for an
alternative function.
2.4. Plasmid construction
We used the pEGFP-N1/Schlafen 3 construct described in Patel et al.
[10] as a template to generate our constructs inserted into the pEGFP-C1
expression vector from Clontech (Mountain View, Ca). The N-terminal,
C-terminal, App and P-loop constructs were ampliﬁed with tailed PCR
from the original pEGFP-C1/Schlafen 3 using speciﬁc primers for the
BamHI and HindII cloning sites. For the NES signal, the leucine-rich
amino acid stretch (ALLKKLVVLLLDE) that represents residues 32–44
of MEK1 was introduced in duplicate into the expression vector
pEGFP-C1 (Clontech) between BamHI and XbalI sites; the EGFP-Slfn3
or N-terminal-EGFP-Slfn3was then inserted so that theNESwas located
at the C-terminal end of each. The point mutations, 128 R to L and 212L
to D, were accomplished using the Quick Change II XL Site-Directed
Mutagenesis kit from Agilent Technologies (Santa Clara, CA). All plas-
mids were puriﬁed via MiniPrep (QIAGEN, Valencia, CA) prior to se-
quencing at the MSU Core Facility. After sequence conﬁrmation, the
plasmids were ampliﬁed and prepared for transient expression using
the QIAGEN MaxiPrep kit.
2.5. Fluorescence confocal microscopy
IEC-6 and Caco-2BBE cells (1.0 × 105) cultured on poly-D-lysine 4-
well culture chambers were transfected with 2.0 μg of the relevant
construct (pEGFP-Slfn3-C1, pEGFP-Slfn3-N1, pEGFP-Slfn3-N-terminus
(1–1049)-C1 or pEGFP-Slfn3-NES-C1) using either FuGENE (Promega,
Madison, WI) or Lipofectamine (Invitrogen, Life Technologies, Grand
Island, NY) according to the manufacturers' directions. Forty eight
hours after transfection, cells were ﬁxed with formalin-free IHC Zinc
ﬁxative (PharmMingen, BD Biosciences, Sand Diego, CA). Endogenous
Slfn3 in IEC-6 cells was detected using a primary Slfn3 antibody from
Santa Cruz Biotechnology, and ﬂuorescent second antibodies (FITC or
Alexa 467 (Abcam)). Cells were incubated with 4′,6-diamidino-2-
phenylindole (DAPI, Zyagen, San Diego, CA) to stain nuclei, and ﬂuores-
cent imageswere captured using anOlympus FluoViewFV1000Confocal
Laser ScanningMicroscope and densitometry quantitatedwith Olympus
Advanced Software (Olympus America, Inc., Center Valley, PA). Images
were processed using Photoshop software (Adobe, San Jose, CA)without
affecting the linearity of the images.
2.6. Luciferase reporter assay
Caco-2BBE cells (1.0 × 104)were seeded in 96-well (0.32 cm2) plates,
and co-transfected the next day with 150 ng/well of the empty
vector (pEGFP-C1, Clontech Laboratories, Inc., Mountain View, CA)
or rat Schlafen 3 DNA constructs (pEGFP-Slfn3, pEGFP-Slfn3-NES,
pEGFP-Slfn3-N terminus, pEGFP-Slfn3-C terminus, pEGFP-Sfn3-
App, pEGFP-Slfn3-Ploop, pEGFP-Slfn3-Mutant 1(R128L) or pEGFP-
Slfn3-Mutant 2 (L212D)) with 50.0 ng/well of the human Villin
(Vil1) or sucrase isomaltase (SI) LightSwitch promoter reportergoclone (Switchgear Genomics, Carlsbad, CA). Thus, cells in each well
received a total of 150 ng of DNA with SLFN3 and Vil1 or SI promoter
reporter constructs at a 3:1 ratio. The DNA was mixed with Opti-MEM
medium (10 μl/well) for 5 min, and FuGENE (Switchgear Genomics,
Carlsbad, CA) was added (3.2 μl/1.0 μg DNA). In a separate experiment,
Caco-2 cells were exposed to 0.1 ng/ml TGF-β or 5mMsodium butyrate
before addition of the Vil1 reporter. Themixturewas incubated at room
temperature for 30min and added to the cells. Forty eight hours after
transfection, the experimentwas terminated by addition of luciferase as
per the manufacturer's recommendations. Brieﬂy, 100 μl/well (buffer
+ substrate) LightSwitch luciferase assay reagent (Switchgear Geno-
mics) was added and incubated for 30 min at room temperature in
the dark. IEC-6 cells were co-transfected similarly with rat villin or SI
promoter reporters (Switchgear Genomics) but Lipofectamine
(Invitrogen) was used as the transfection reagent and the experiment
was terminated after 24 h. Relative Luminescence (RLU) was mea-
sured using a VERITAS Microplate Luminometer (Turner Biosystems,
Sunnyvale, CA).2.7. Statistical analysis
Densitometric results for cytosolic/nuclear protein expression were
normalized to their respective controls and signiﬁcance determined
by Students' T-test. Results of the luciferase reporter assays were
normalized to the basal promoter activity, villin or SI, because of varia-
tions in the RLU readings between assays. Signiﬁcance of the results,
presented as X± SE,was ascertained by one-way ANOVAwith Pairwise
Multiple Comparisons (Holm–Sidak Method).3. Results
3.1. Cytosolic Slfn3 enhances villin promoter activity
3.1.1. Cellular distribution of exogenously expressed Slfn3mimics that of the
endogenous molecule in IEC-6 cells
Since Caco-2 cells do not normally express Slfn3 and addition of the
EGFP tag could conceivably alter cellular Slfn3 distribution, we ﬁrst
assessed endogenous Slfn3 protein distribution in rat intestinal epithe-
lial IEC-6 cells by Western blot. In IEC-6 cells, Slfn3 was predominantly
cytosolic (73.5 ± 2.9% of total), with much less Slfn3 in the nuclear
fraction (25.6 ± 2.9%, n = 8). Successful fractionation was validated
by demonstrating enrichment of Rho-GDI in the cytoplasmic fraction
and Lamin B1 in the nuclear fraction (Fig. 1A).We conﬁrmed this distri-
bution by immunoﬂuorescent staining, using antibody to Slfn3 and a
FITC-tagged secondary antibody (Fig. 1B). Visible nuclear staining
(Fig. 1B part a) clearly co-localized with the DAPI nuclear stain
(Fig. 1B part c). Fluorescence analysis of 30 cells indicated that 73 ±
11% of the total immunoreactive signal for Slfn3 signal is found in the
cytosol while 27 ± 2% resides in the nucleus, nearly identical to the
results obtained with cell fractionation.
We then determined whether exogenous p-EGFP-Slfn3 distribution
parallels that of endogenous Slfn3 in IEC-6 cells. Since the distribution of
each of our wild-type, full length constructs, pEGFP-Slfn3-C1 and
pEGFP-Slfn3-N1, was similar regardless of the position of the GFP tag
(Supplementary Fig. D), we chose the N-terminal tagged pEGFP-Slfn3-
C1 for all subsequent studies. Fig. 1C illustrates the results of co-
localization experiments. In the transfected cells, exogenous pEGFP-
Slfn3 was the most abundant in the cytosol but was also found in the
nucleus (Fig. 1C part a); immunoreactive endogenous Slfn3 showed a
similar pattern (Fig. 1C part c). The Slfn3 antibody reacts with both
the endogenous and the exogenously expressed Slfn3 resulting in a
stronger signal where they overlap in the transfected cells. Merging of
the images (Fig. 1C part e) and the addition of DAPI (Fig. 1C parts b, d,
and f) further support this co-localization.
Fig. 1. Predominantly cytosolic and modest nuclear localization of exogenously expressed Slfn3 mimics that of the endogenous molecule in IEC-6 cells. (A) Slfn3 protein abundance is
greatest in the cytosol in fractionated rat IEC-6. Bars represent densitometric analysis as a ratio of the total immunoreactivity (*p b 0.05, n = 8). A representative gel is shown above;
Rho GDI and Lamin B were used as cytosolic and nuclear markers. (B) Confocal images conﬁrm that endogenous immunoreactive Slfn3 is found in the nucleus but is predominantly
localized to the cytosol: (a) Slfn3 primary antibody/FITC secondary antibody, (b) DAPI nuclear stain, (c) merged image, and (d) no primary antibody control with DAPI stain. Represen-
tative of 8 similar images. (C) (a) Exogenously expressed Slfn3 (pEGFP-Slfn3-C1) and (b) endogenous Slfn3 co-localize in IEC-6 cell (c). Cytosolic/nuclear expression is further delineated
with nuclear DAPI staining (b, d, f). Representative of 6 similar.
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sion in Slfn3-null Caco-2 cells
Cellular localization of the rat pEGFP-Slfn3-C1 product in human
Caco-2 cells was similar to both endogenous and exogenous Slfn3
expression in rat IEC-6 cells: mostly cytosolic with a small amount of
nuclear expression (Fig. 2A). Two representative ﬁelds are shown be-
cause of low transfection efﬁciency (pEGFP (a, b); nuclear DAPI (c, d)).
Merged images (e, f) highlight the localization of the expressed product.
To verify that transfected Caco-2 cells are an appropriate model, we
measured villin and SI promoter activity in both cell lines. Non-
normalized RLU's (Table 1) demonstrated several fold higher basal
activity of the human villin promoter in Caco-2 than of the rat promoter
in IEC-6 cells, but the response to exogenous expression of Slfn3 was
of similar magnitude in each cell type. The differences in baseline pro-
moter activity most likely reﬂect the nature of the reporter constructs
themselves, which necessarily vary between rat IEC-6 cells and human
Caco-2 cells, aswell as differences in the transfection efﬁciency achieved
in each cell line. To further validate the use of Caco-2 cells to study Slfn3
biology, we compared villin promoter activity in response to exogenous
Slfn3 to the response of villin promoter activity to two known differen-
tiation factors, TGF-β and sodium butyrate that we have previously
studied in intestinal epithelial and other cells [31–36]. Responses to
these disparate stimuli were relatively similar (Fig. 2B), conﬁrming
that exogenous Slfn3 expression promotes a physiologically relevant
response in the pEGFP-Slfn3-plasmid transfected Caco-2 cells. In aseparate study, we infected Caco-2 cells with an adenovirus coding for
Slfn3 and GFP or a control adenovirus coding only for GFP, each previ-
ously described, and conﬁrmed that there was no difference in cell
number between the two cell populations at 24 h (data not shown),
consistent with our previous observation in rat jejunal epithelium
in vivo [20], and with the previous observation that knockdown of
Slfn3 does not prevent the mitogenic effects of repetitive deformation
or EGF in IEC-6 cells in vitro [18]. Althoughwe did not study this further
speciﬁcally here as beyond the scope of the current investigation, Caco-
2 cells also respond to repetitive deformation and EGF similarly to IEC-6
cells [37].3.1.3. Slfn3 enhances villin promoter activity from a cytosolic location
To further determinewhether cytosolic Slfn3maintained full activity,
we attached a nuclear exclusion sequence (NES) to our Slfn3 plasmid,
monitored its localization by confocal microscopy and measured its
effect on villin promoter activity in human Slfn3-null Caco-2 cells. As
shown in Fig. 2C, pEGFP-Slfn3 ﬂuorescence was mostly conﬁned to
the cytosol, with slight nuclear immunoﬂuorescence (a, b). No nuclear
ﬂuorescence could be discerned in the EGFP-Slfn3-NES cells (c, d). Villin
promoter activity (Fig. 2D) was signiﬁcantly elevated in the Slfn3-
transfected cells and greatest in the Slfn3-NES expressing cells
(p b 0.05 by one-way ANOVA; n = 4), indicating that Slfn3 initiates
its effects from its cytosolic location and not by direct nuclear action.
Fig. 2. Exogenously expressed Slfn3 stimulates villin promoter activity from a cytosolic location in Slfn3-null Caco-2 cells. (A) Two representative confocalmicrographs of pEGFP-Slfn3-C1
expressed in Caco-2 cells demonstrate strong cytosolic andminor nuclear expression (a, b). DAPI-stained nuclei reﬂect the number of non-transfected cells (c, d), Merged images
(e, f) conﬁrm that the pEGFP-Slfn3-C1 construct is expressed in Caco-2 as it is in IEC-6 cells. (B) Exogenous Slfn3 enhances villin promoter activity similarly to TGF-β and sodium
butyrate (*p b 0.05; n = 3–6). (C) Cellular localization of GFP-tagged wild-type Slfn3 (pEGFP-Slfn3) transfected into Slfn3-null Caco-2 cells (a, b) and cytosolic localization with
the addition of a nuclear exclusion sequence (pEGFP-Slfn3-NES; c, d) is shown in these representative confocal micrographs. (D) Villin promoter activity is greater in Caco-2 cells
transfected with the Slfn3-NES construct (S3-NES) than with the full-length construct (Slfn3) (*p b 0.05 vs control, #p b 0.05 vs full length by one way ANOVA, n = 4).
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3.2.1. Aminopeptidase
The aminopeptidase functional annotation is based on the complete
preservation of the C-terminal catalytic domain between 3kzw and
known leucyl aminopeptidases and their structures, such as Protein
Data Bank entry 3kqx from Plasmodium falciparum (personal communi-
cation, Dr. Boguslaw Nocek, Argonne National Laboratory). This 293-
residue match to the rSlfn3 sequence, with 23% sequence identity, is
signiﬁcant (only 1% chance of occurring at random) and close to the
threshold that guarantees 3-dimensional structural homology (24.8%
identity over more than 80 residues [38]). Based on this homology,
the active site residues in 3kzw include Asp264, Asp341, and Glu343,
of which the latter is conserved with Glu206 in the KENIL motif of
rSlfn3 (Fig. 3A). The partial conservation of catalytic residues suggests
that rSlfn3 could bind anN-terminal peptide similarly to the aminopep-
tidase while not sharing its peptide bond cleavage function.Table 1
Villin and sucrase isomaltase (SI) promoter activity in IEC-6 vs. Caco-2 cells.
IEC-6 cells Caco-2 cells
Villin promoter
Basal villin 1115 ± 93 15874 ± 2394
Slfn3 1944 ± 56⁎ 28489 ± 5001⁎
N-terminal Slfn3 2178 ± 82⁎⁎ 42180 ± 9395⁎⁎
SI promoter
Basal SI 1065 ± 69 3060 ± 198
Slfn3 2022 ± 75⁎ 4227 ± 143⁎
N-terminal Slfn3 1844 ± 66⁎ 4166 ± 196⁎
⁎ p b 0.05 vs Basal.
⁎⁎ p b 0.05 vs Slfn3.3.2.2. Conserved motifs in Schlafens and the P-loop domain
According to ConSurf analysis [39] of hundreds of sequences with
30–80% sequence identity to rSlfn3, the three most highly conserved
motifs in the N-terminal half of Schlafens begin at residue 47 in
rSlfn3: AvCTLLNSGGGVAKARI, residue 217: SSFANAdGGYlFiGLDG, and
residue 291: SFVCALrVerFCCaVFA, where the lower case letters repre-
sent moderately conserved positions. The region of signiﬁcant match
between rSlfn3 and the sequence motifs shared by divergent AAA P-
loop proteins including 3n70 begins before the second motif, at rSlfn3
residue 199: EVK… The region of the strongest P-loop match starts
ﬁve residues prior to the second conserved Schlafen motif, at residue
212, and includes LPQ… FIG. The P-loop homology continues through
the end of the third motif, where the similarity ends at…SCVK, residue
331 (Fig. 3A). The ATP-binding Walker A motif GAPGTGR near the N-
terminus of the P-loop domain (Fig. 3B) is not conserved with rSlfn3,
due to itsmatch to divergent rather than canonical AAAP-loop domains.
Together, these results suggest that this region in rSlfn3 folds like a
P-loop domain but would not be expected to bind or hydrolyze ATP in
the P-loop region.3.2.3. TheN-terminal segment of Slfn3 is sufﬁcient for villin and SI expression
We therefore sought to determinewhether the N-terminal segment
of the Slfn3 molecule that exhibits the greatest homology to both the
App and P-loop structures promotes its differentiating effects, by de-
signing the truncations andmutations described in Section 2.3 and illus-
trated in Fig. 3. In these studies, we again utilized human Caco-2
intestinal epithelial cells as a Slfn3-null cell. We initially ascertained
that cellular distribution of the expressed N-terminal construct in
the Caco-2 cells was the same as in the IEC-6 cells by confocal microsco-
py. Fluorescence was detected in both the nuclear and cytosolic com-
partments of each cell type, again with most of the expression in the
Fig. 3. BLAST-identiﬁed functional domain matches with rSlfn3, and corresponding constructs designed to test the correlation of Slfn3 function with maintenance of aminopeptidase-like
(PDB entry 3kzw) versus AAA P-loop-like (PDB entry 3n70) function. (A) Sequence alignment, with boldfaced positions in the rSlfn3 sequence indicating the threemost-conservedmotifs
in Schlafens (AVCTLLNSGGGVAKARI, SSFANADGGYLFIGLDG, and SFVCALRVERFCCAVFA). The position of theWalker A P-loopmotif in the 3n70 sequence, GAPGTGR, appears in boldface,
and two site-directedmutations in rSlfn3, Arg129Leu and Leu212Asp, are highlighted in red. (B) Themain-chain fold of the P-loop domain crystal structure (PDB entry 3n70), correspond-
ing to the BLAST Conserved Domainmatch in rSlfn3. The highest-homology region, PQLN… VLS, surrounding and including the second conserved Schlafen motif, is highlightedwith side
chains in yellow. TheWalker Amotif, which is not conserved in rSlfn3, consistent with itsmatch to divergent AAA domains, is shownwith side chains inmagenta. Theﬁgurewas rendered
with PyMOL (Schrödinger LLC, NY).
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product (Fig. 4 part a) co-localized with endogenously expressed Sﬂn3
(e). Two representative images of transfected Caco-2 cells also demon-
strate predominant cytosolic staining (Fig. 4 parts g, i) andminor nuclear
expression (Fig. 4 parts h, j).
Villin promoter activity was signiﬁcantly enhanced by co-transfection
with the full Slfn3 construct and to an even greater extent by transfection
with the N-terminal portion of the molecule (p b 0.05 by one-way
ANOVA; n = 4). In contrast, luciferase activity in cells transfected
with the C-terminal segment was not elevated above basal levels
(Fig. 5A). However, pointmutation of anN-terminal domain residue re-
quired for App activity (Arg129 to Leu) and a second position conserved
across Schlafen proteins but tolerant of mutation in other P-loop pro-
teins (Leu212 to Asp) did not disrupt villin promoter activity (Fig. 5B),
supporting P-loop rather than App-like function.We then investigat-
ed whether cytosolic retention of the N-terminal construct was impor-
tant to its activity. Villin expression was signiﬁcantly elevated after
co-transfection with the N-terminal-NES construct, albeit to a slightlylesser extent than that of the N-terminal construct alone (Fig. 5C). We
conﬁrmed these results using a promoter for sucrase-isomaltase (SI),
another marker of enterocytic differentiation. As in our observations
with the villin promoter, increased SI promoter activity was observed
after transfection of either wild type Slfn3 or the N-terminal segment,
and the two point mutations had no effect (Fig. 5D).
3.3. The P-loop segment, totally contained within the N-terminal and
App (aminopeptidase-like) domains of Slfn3, stimulates both villin
and SI expression
Analysis of the N terminal half of Slfn3 identiﬁed two potential func-
tions for this region based on homology to an aminopeptidase, and in a
more compact region, to a divergent AAA P-loop domain (Fig. 3A). We
therefore further truncated the N-terminal domain to create two small-
er proteins corresponding to each of these motifs. Transfection with
either the App segment or the smaller P-loop domain each signiﬁcantly
increased villin promoter activity (Fig. 6A). Analysis by ANOVA revealed
Fig. 4. Exogenously expressed Slfn3 N-terminal domain localizes predominantly to the cytoplasm in IEC-6 and Slfn3-null Caco-2 cells. Confocal localization of N-terminal Slfn3 (A) closely
matches that of the endogenously expressed Slfn3 (C) as shown in the merged image (E). Each image is shown with DAPI stain for clarity (B, D, F). Similar N-terminal localization in
transfected Caco-2 cells (G, I) is conﬁrmed by DAPI (H, I). IEC-6: representative of four similar; Caco-2: two representative images of four.
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even the full-length Slfn3 construct (p b 0.05, n=3). SI promoter activ-
ity was also signiﬁcantly enhanced by each construct, but all appeared
to be equally effective (Fig. 6B). The results suggest that the P-loop
domain is responsible for the villin and SI promoter stimulatory effect
of the larger N-terminal and App domains.
4. Discussion
The data presented above indicate that, although Slfn3 residesmostly
in the cytoplasm, it engenders nuclear effects including villin and SIFig. 5.Villin and sucrase isomaltase (SI) promoter stimulatory activity resides in theN-terminal
effect on villin promoter activity than the full Slfn3 construct (*pb 0.05 vs control, #pb 0.05 vs th
N-terminal domain residues (A129L and L212D) does not reduce villin promoter activity when
tion of the N-terminal construct (Slfn3-NES) enhances villin promoter activity but to a lesser de
construct). (D) SI promoter activity is increased by co-transfection of the full-length (Slfn3) and
vs control). (One way ANOVA and n = 4 for each of the above).promoter transcriptional activation. This suggests that Slfn3 acts via
one or more intermediate proteins, initiating a signaling cascade in
the cytosol that ultimately terminates in the nucleus. It has been
suggested that Slfns may act within the nucleus as DNA/RNA helicases
as they possess a highly conserved sequence (CDD:COG2865) with
similarity to putative transcriptional regulators [4]. Indeed, others have
demonstrated that Slfn1, a short Slfn also found in the cytosol, is trans-
ported to the nucleus after binding to the Hsp40 chaperone protein
DnaJB6 where it precipitates cell cycle arrest [40]. However, our results
with the EGFP-Slfn3-NES construct argue against a direct action for
Slfn3 within the nucleus.portion of Slfn3. (A) Co-transfection of the Slfn3N-terminal domain (N-term) has a greater
e full-length construct); the C-terminal region (C-term) has noeffect. (B) Pointmutation of
compared to the N-terminal (N-term) construct (*p b 0.05 vs control). (C) Cytosolic reten-
gree than the N-terminal construct itself (*p b 0.05 vs control, #p b 0.05 vs the N-terminal
N-terminal (N-term) Slfn3 constructs and is unchanged by the point mutations (*p b 0.05
Fig. 6. The P-loop, the smallest segment within the N-terminal domain, increases both villin and SI promoter expression. (A) Transfection with either the aminopeptidase (App) or the
smaller P-loop domain each enhances villin promoter activity. The P-loop effect is greater than that of the full-length Slfn3 construct (*p b 0.05 vs control, #p b 0.05 vs full-length
Slfn3 by one way ANOVA, n = 3). (B) SI promoter activity is equally increased by the full-length Slfn3, App and P-loop constructs (*p b 0.05 vs control, n = 3).
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can be obtained by manipulating either large sections of the protein by
truncation [41] or by point mutation of residues likely to be critical for
function. For example, the N-terminal region of p97/VCP, a ubiquitous
AAA ATPase, was shown to be required for ATPase activity, while the
C-terminal domain proved to be necessary for oligomer stability [42].
The only such study done in Slfns reported that a Slfn1 mutant lacking
27 N-terminal amino acids abrogated its growth inhibitory properties
when overexpressed in NIH 3T3 cells [4]. The same authors described
the gene organization of the long Slfns and ascribed putative DNA/RNA
helicase function to the extended C-terminal domain, lacking in short
and intermediate Slfns, on the basis of recurrent motifs with structural
homology to known Superfamily I helicases [4]. Slfns have been shown
to have regions of homology with AAA family ATPases [4,22,23], and
here we show this is the case for an N-terminal region in rSlfn3. The
AAA superfamily includes a broad range of functions: DNA and RNA
helicases (some of which are cytosolic in action), DNA clamp loaders,
DNA replication initiators, protein remodelers including proteasomal
subunits, and Mg2+ chelatases [43]. Some act as molecular switches
and others are processive machines. AAA and AAA+ domains both
contain an N-terminal P-loop or Rossmann fold associated with
ATP binding and hydrolysis, plus a C-terminal alpha-helical domain.
AAA+ family members also share a conserved “second region of
homology” (SRH) in the C-terminal domain [44]; this SRH was not
matched in rSlfn3.
AAA ATPases belong to the larger P-loop NTPase family character-
ized byATP bindingdomains that containWalker A andWalker Bmotifs
that bind ATP/GTP [45]. The divergent AAA superfamily members are
overall similar to those with the canonical P-loop fold, while showing
sequence divergence in the Walker ATP binding motifs including the
P-loop itself. AAA ATPases form oligomeric assemblies with a number
of factors and exert their effects through energy-dependent conforma-
tional changes [24]. Although rSlfn3 does not contain canonical Walker
motifs and Slfns have not been shown to hydrolyze ATP, structural
homology led us to focus on the N-terminal segment of rSlfn3 as a pos-
sible binding site for protein partners. Further search revealed a match
between rSlfn3 and the P-loop domain of PDB entry 3n70. Full mainte-
nance of downstream promoter activity upon critical mutations remov-
ing half of the potential aminopeptidase domain and one of its critical
active-site residues supports that aminopeptidase activity is unlikely
for rSlfn3. This is consistent with no observation of enzymatic function
for Schlafens in the literature. Since the smaller P-loop construct was
fully active, the N-terminal sequence upstream of the P-loop sequence
is unlikely to be involved in rSlfn3 stimulation of promoter activity. Co-
transfection with a construct containing the 175-residue3n70P-loop
segment was as effective as the entire Slfn3 construct in stimulating
both villin and SI promoter activity.
While villin promoter activity in response to transfectionwith theN-
terminal construct was signiﬁcantly greater than that to the full-lengthSlfn3, no such difference was seen with the SI promoter. These results
were replicated in the IEC-6 cells where SI activation also appeared
similar between the N-terminal and full-length constructs (Table 1),
suggesting that the effect is not cell-line speciﬁc. Although they contain
some common response elements, organization of the upstream reg-
ulatory region of villin and sucrase-isomaltase differs, reﬂecting the
complex control of their expression [46–49]. For example, nutrient
availability plays a greater role in SI expression [50]. Thus, it is possi-
ble that the downstream signal generated by the full-length and N-
terminal Slfn sequences may bind to different response elements in
each promoter sequence. More speciﬁcally, the C-terminal region of
Slfn3may have an inhibitory effect on the villin promoter that is absent
in the sucrase-isomaltase promoter.
Rodents are known to express two intermediate Slfns, Slfn3 and
Slfn4 [1,21]. Although highly homologous, mouse Slfn3 and Slfn4 ap-
pear to be differentially regulated in hematopoietic cells [4–6], suggest-
ing that they may play different roles in the differentiation and
maturation of these cells. In the rat, there is an extension with an alter-
nate start site at the 5′ end of the Slfn4 coding sequence and a small
alignment gap that was used in the design of the present Slfn3 construct
but the two sequences appear to yield a nearly identical product.
Whether Slfn4 differs in function in the rat remains unknown. Indeed,
there is little information on how intermediate and other Slfns carry
out their actions. Our ﬁndings that a speciﬁc N-terminal domain is re-
quired for Slfn3 stimulation of differentiation in intestinal epithelial
cells may have broader implications. If a similar mode of action applies
to other Slfns, it may shed light on Slfnmodulation of leukocytematura-
tion and of growth and differentiation in other tissues.
In summary, although the 3-D structure of Slfn3 has not yet been
determined, structural and functional homology predictions can be
used to design constructs to test stable structural and functional
domains, with the eventual goal of identifying binding partners that
transduce speciﬁc Slfn-mediated signals. The data presented above
point to the P-loop domain as able to stimulate villin and SI expression,
and thus a promising candidate to examine further as a partner in mo-
lecular signaling interactions, an important step towards understanding
Slfn mechanisms of action.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2014.09.017.Acknowledgements
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